Mutagenicity/Genotoxicity with Endogenous PGH Synthase-2

内源性 PGH 合酶 2 的致突变性/基因毒性

基本信息

  • 批准号:
    6801756
  • 负责人:
  • 金额:
    $ 2.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-09-30 至 2004-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Prostaglandin H synthase (PGHS) plays a significant role in inflammation and carcinogenesis. PGHS form 2 (PGHS-2) induced by mitogens, growth factors and tumor promotors causes mutagenicity and genotoxicity. A bacterial test is not suitable because reactive toxicants produced by PGHS-2 are short-lived and cannot easily cross the bacterial membrane. Our objective is to develop colorimetric/chemiluminescent and fluorescent real-time quantitative PCR (QPCR) assays to quantitate DNA damage mediated by endogenous human PGHS-2. In Phase I, we expressed human PGHS-2 in human DNA repair deficient fibroblast cell line, XPA, treated the cells with benzo(a)pyrene-7,8-dihydrodiol and measured DNA damage by QPCR of 16.2 kb mitochondrial DNA using colorimetric/chemiluminescent assays. In Phase II, we will improve the colorimetric/chemiluminescent QPCR assay internal control DNAs and develop a fluorescent real-time QPCR assay. We will also develop QPCR assays with a DNA damage repair-proficient human fibroblast cell line after transfection of the cells with a PGHS-2 gene-containing vector. QPCR assays will also be developed with human PGHS-1 expressing XPA. Utilities of the assays will be explored by treatment of the cells with several environmental toxicants. PROPOSED COMMERCIAL APPLICATION: Increased expression of PGHS-2 may lead to development of human tumors including colon cancer. Reliable mutagenicity and genotoxicity assays with PGHS-2 expressed in eukaryotic cells is in great demand. Thus, facile colorimetric/ECL and fluorescent Real-Time quantitative PCR (QPCR) assays will be developed with human PGHS-2 :expressed in human DNA repair deficient and proficient fibroblasts. The QPCR assay kits will be marketed to screen PGHS-2-dependent promutagens and DNA damaging agents as well as chemopreventive agents.
描述(由申请人提供):前列腺素H合成酶(PGHS)起作用

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hyesook Kim其他文献

Hyesook Kim的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hyesook Kim', 18)}}的其他基金

Glycoproteins and Glycan-Binding IgGs: Biomarkers for Cancer and Inflammatory Di
糖蛋白和聚糖结合 IgG:癌症和炎症性疾病的生物标志物
  • 批准号:
    8250520
  • 财政年份:
    2012
  • 资助金额:
    $ 2.52万
  • 项目类别:
Glycoproteins and Glycan-Binding IgGs: Biomarkers for Cancer and Inflammatory Di
糖蛋白和聚糖结合 IgG:癌症和炎症性疾病的生物标志物
  • 批准号:
    8535687
  • 财政年份:
    2012
  • 资助金额:
    $ 2.52万
  • 项目类别:
Targeted Antibody Microarrays:Tool for Toxicoproteomics
靶向抗体微阵列:毒理学蛋白质组学工具
  • 批准号:
    7120162
  • 财政年份:
    2005
  • 资助金额:
    $ 2.52万
  • 项目类别:
Targeted Antibody Microarrays:Tool for Toxicoproteomics
靶向抗体微阵列:毒理学蛋白质组学工具
  • 批准号:
    6938769
  • 财政年份:
    2005
  • 资助金额:
    $ 2.52万
  • 项目类别:
"Xenopus Microarrays: A Tool for Molecular Toxicology"
“非洲爪蟾微阵列:分子毒理学的工具”
  • 批准号:
    6690273
  • 财政年份:
    2003
  • 资助金额:
    $ 2.52万
  • 项目类别:
Fetal Alcohol Syndrome Biomarkers by Antibody Microarr
Antibody Microarr 胎儿酒精综合症生物标志物
  • 批准号:
    6801387
  • 财政年份:
    2003
  • 资助金额:
    $ 2.52万
  • 项目类别:
"Xenopus Microarrays: A Tool for Molecular Toxicology"
“非洲爪蟾微阵列:分子毒理学的工具”
  • 批准号:
    6799219
  • 财政年份:
    2003
  • 资助金额:
    $ 2.52万
  • 项目类别:
Fetal Alcohol Syndrome Biomarkers by Antibody Microarray
通过抗体微阵列检测胎儿酒精综合症生物标志物
  • 批准号:
    6699092
  • 财政年份:
    2003
  • 资助金额:
    $ 2.52万
  • 项目类别:
Mutagenicity/Genotoxicity with Endogenous PGH Synthase-2
内源性 PGH 合酶 2 的致突变性/基因毒性
  • 批准号:
    6405320
  • 财政年份:
    2001
  • 资助金额:
    $ 2.52万
  • 项目类别:
Mutagenicity/Genotoxicity with Endogenous PGH Synthase-2
内源性 PGH 合酶 2 的致突变性/基因毒性
  • 批准号:
    6518251
  • 财政年份:
    2001
  • 资助金额:
    $ 2.52万
  • 项目类别:

相似海外基金

DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
  • 批准号:
    10748479
  • 财政年份:
    2024
  • 资助金额:
    $ 2.52万
  • 项目类别:
CAREER: Mechanisms and consequences of epigenome-recruited DNA repair systems in plants
职业:植物中表观基因组招募的 DNA 修复系统的机制和后果
  • 批准号:
    2338236
  • 财政年份:
    2024
  • 资助金额:
    $ 2.52万
  • 项目类别:
    Continuing Grant
Elucidation of the molecular link between DNA repair and mitochondrial nucleic acid metabolism
阐明DNA修复和线粒体核酸代谢之间的分子联系
  • 批准号:
    23K07078
  • 财政年份:
    2023
  • 资助金额:
    $ 2.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
  • 批准号:
    10550045
  • 财政年份:
    2023
  • 资助金额:
    $ 2.52万
  • 项目类别:
Structural studies for understanding the mechanism of DNA repair in chromatin
了解染色质 DNA 修复机制的结构研究
  • 批准号:
    23H05475
  • 财政年份:
    2023
  • 资助金额:
    $ 2.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
DNA Repair State Machines
DNA 修复状态机
  • 批准号:
    EP/X027406/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.52万
  • 项目类别:
    Research Grant
Multifaceted regulation of the DNA repair machinery and suppression of aberrant transcription by telomere proteins
DNA 修复机制的多方面调控和端粒蛋白异常转录的抑制
  • 批准号:
    2246561
  • 财政年份:
    2023
  • 资助金额:
    $ 2.52万
  • 项目类别:
    Standard Grant
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
  • 批准号:
    10666307
  • 财政年份:
    2023
  • 资助金额:
    $ 2.52万
  • 项目类别:
Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
针对癌症治疗的同源定向 DNA 修复的天然产物抑制剂
  • 批准号:
    10651048
  • 财政年份:
    2023
  • 资助金额:
    $ 2.52万
  • 项目类别:
Modeling the Responsiveness of Sensitive Populations to Genotoxic Agents Using DNA Repair Inhibitors
使用 DNA 修复抑制剂模拟敏感人群对基因毒性药物的反应性
  • 批准号:
    10734425
  • 财政年份:
    2023
  • 资助金额:
    $ 2.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了